We also demonstrate that patients with RA show dysregulation of the S1P/S1PR1 axis in ECs in favor of vascular permeability, supporting further studies to specifically target this pathway to treat inflammatory arthritis. The gene discussed is S1PR1; the disease is rheumatoid arthritis.